Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121912423 | 12191242 | 3 | F | 20160817 | 20160318 | 20160823 | EXP | US-JNJFOC-20160313874 | JANSSEN | 0.00 | E | M | Y | 68.04000 | KG | 20160823 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121912423 | 12191242 | 1 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 22406 | TABLET | ||||||||
| 121912423 | 12191242 | 2 | SS | WARFARIN | WARFARIN | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121912423 | 12191242 | 1 | Thrombosis |
| 121912423 | 12191242 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121912423 | 12191242 | OT |
| 121912423 | 12191242 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121912423 | 12191242 | Arrhythmia | |
| 121912423 | 12191242 | Chronic obstructive pulmonary disease | |
| 121912423 | 12191242 | Haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121912423 | 12191242 | 1 | 20150504 | 0 |